SCHEMBL9912493

SCHEMBL9912493

CC(C)NSc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 2/20 0.42
▸ MAOA P21397 1/20 0.40
▸ MAOB P27338 1/20 0.40
▸ HSD17B10 Q99714 2/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ MAPT P10636 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ MGLL Q99685 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.37
▸ LMNA P02545 3/20 0.37
▸ L3MBTL1 Q9Y468 2/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ THRB P10828 1/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ ALOX12 P18054 1/20 0.37
▸ RECQL P46063 1/20 0.37
▸ ATM Q13315 1/20 0.37
▸ MTNR1A P48039 3/20 0.36
▸ MTNR1B P49286 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15294706 0.78 HPGD (0.41) TDP1MAPTHPGDALDH1A1LMNA
SCHEMBL7805609 0.76 MTNR1A (0.42) SMN1; SMN2LMNAL3MBTL1TSHRMTNR1A
SCHEMBL6489465 0.76 MTNR1A (0.42) SMN1; SMN2LMNAL3MBTL1TSHRMTNR1A
SCHEMBL6489470 0.76 MTNR1A (0.42) SMN1; SMN2LMNAL3MBTL1TSHRMTNR1A
SCHEMBL12487706 0.74 SIGMAR1 (0.57) CYP3A4TSHR
SCHEMBL22219857 0.74 HDAC4 (0.39) TDP1SMN1; SMN2MAPTHPGDALDH1A1
SCHEMBL18757779 0.74 CYP3A4 (0.41) TDP1MAOAMAPTALDH1A1LMNA
SCHEMBL19370719 0.74 SMN1; SMN2 (0.46) MAOAMAOBSMN1; SMN2ALDH1A1LMNA
SCHEMBL19248314 0.73 LMNA (0.46) SMN1; SMN2HPGDALDH1A1LMNAMTNR1A
SCHEMBL19248316 0.73 LMNA (0.46) SMN1; SMN2HPGDALDH1A1LMNAMTNR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8198458-B2 Non-nucleoside reverse transcriptase inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-12 — — US disclosed
Send feedback